Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy

INTRODUCTION: Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by mutations of GLA gene leading to reduced α-galactosidase activity and resulting in a progressive accumulation of globotriaosylceramide (Gb3) and its deacylated derivative, globotriaosyl-sphingosine (Lyso-G...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzen, Daniel, Haile, Sarah R, Kasper, David C, Mechtler, Thomas P, Flammer, Andreas J, Krayenbühl, Pierre A, Nowak, Albina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Orphan Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922571/
https://www.ncbi.nlm.nih.gov/pubmed/29713479
http://dx.doi.org/10.1136/bmjresp-2018-000277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922571/
https://www.ncbi.nlm.nih.gov/pubmed/29713479
http://dx.doi.org/10.1136/bmjresp-2018-000277

Ejemplares similares